1. Etoricoxib: MHRA recommends reduced dose

   News item 29 October 2016 Pages: 1 - 1

2. Falsely elevated estradiol levels with fulvestrant

   News item 29 October 2016 Pages: 2 - 2

3. Keppra oral solution should be used with dosing syringe

   News item 29 October 2016 Pages: 3 - 3

4. Medsafe: ticagrelor not linked with depression, suicidality

   News item 29 October 2016 Pages: 4 - 4

5. Metformin: expanded use for patients with kidney impairment

   News item 29 October 2016 Pages: 5 - 5

6. Teva's levothyroxine tablets relaunched into UK market

   News item 29 October 2016 Pages: 6 - 6

7. AHA: beware of drug interactions with statins, CV therapies

   Review 29 October 2016 Pages: 7 - 7

8. Antiandrogens increase risk of dementia

   Clinical study 29 October 2016 Pages: 8 - 8

9. Calcium supplementation increases risk of dementia

   Clinical study 29 October 2016 Pages: 9 - 9

10. Clozapine safe in patients with benign neutropenia

    Clinical study 29 October 2016 Pages: 10 - 10

11. GLP-1 analogues increase risk of breast cancer?

    Clinical study 29 October 2016 Pages: 11 - 11

12. Pandemrix: little apparent risk for congenital malformation

    Clinical study 29 October 2016 Pages: 12 - 12

13. Adalimumab

    Case report 29 October 2016 Pages: 13 - 13

14. Afatinib

    Case report 29 October 2016 Pages: 14 - 14

15. Afatinib

    Case report 29 October 2016 Pages: 15 - 15

16. Afatinib

    Case report 29 October 2016 Pages: 16 - 16

17. Afatinib

    Case report 29 October 2016 Pages: 17 - 17

18. Albendazole/ganciclovir

    Case report 29 October 2016 Pages: 18 - 18

19. Alectinib

    Case report 29 October 2016 Pages: 19 - 19

20. Alemtuzumab

    Case report 29 October 2016 Pages: 20 - 20

21. Alteplase

    Case report 29 October 2016 Pages: 21 - 21

22. Alteplase

    Case report 29 October 2016 Pages: 22 - 22

23. Alteplase

    Case report 29 October 2016 Pages: 23 - 23

24. Aminosalicylic acid/ethionamide

    Case report 29 October 2016 Pages: 24 - 24

25. Amiodarone

    Case report 29 October 2016 Pages: 25 - 25

26. Amoxicillin/clavulanic acid

    Case report 29 October 2016 Pages: 26 - 26

27. Amrubicin/cisplatin/irinotecan

    Case report 29 October 2016 Pages: 27 - 27

28. Antineoplastics

    Case report 29 October 2016 Pages: 28 - 28

29. Antineoplastics

    Case report 29 October 2016 Pages: 29 - 29

30. Antineoplastics

    Case report 29 October 2016 Pages: 30 - 30

31. Antineoplastics

    Case report 29 October 2016 Pages: 31 - 31

32. Antineoplastics

    Case report 29 October 2016 Pages: 32 - 32

33. Antineoplastics

    Case report 29 October 2016 Pages: 33 - 33

34. Antineoplastics

    Case report 29 October 2016 Pages: 34 - 34

35. Antineoplastics/defibrotide

    Case report 29 October 2016 Pages: 35 - 35

36. Antituberculars

    Case report 29 October 2016 Pages: 36 - 36

37. Antituberculars

    Case report 29 October 2016 Pages: 37 - 37

38. Antituberculars

    Case report 29 October 2016 Pages: 38 - 38

39. Astaxanthin/berberine/folic acid/monascus/policosanol/ubidecarenone/rosuvastatin/sertraline interaction

    Case report 29 October 2016 Pages: 39 - 39

40. Azathioprine

    Case report 29 October 2016 Pages: 40 - 40

41. BCG

    Case report 29 October 2016 Pages: 41 - 41

42. Beclometasone

    Case report 29 October 2016 Pages: 42 - 42

43. Betamethasone

    Case report 29 October 2016 Pages: 43 - 43

44. Bevacizumab

    Case report 29 October 2016 Pages: 44 - 44

45. Biotin

    Case report 29 October 2016 Pages: 45 - 45

46. Calcium acetate

    Case report 29 October 2016 Pages: 47 - 47

47. Calcium polystyrene sulfonate

    Case report 29 October 2016 Pages: 48 - 48

48. Canagliflozin

    Case report 29 October 2016 Pages: 49 - 49

49. Capecitabine

    Case report 29 October 2016 Pages: 50 - 50

50. Capecitabine/platinum complexes/vinorelbine

    Case report 29 October 2016 Pages: 51 - 51